(Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"(Ultra‐)long‐acting Insulin Analogues Versus NPH Insulin (human Isophane Insulin) for Adults With Type 2 Diabetes Mellitus." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438063/all/repview. Accessed 06 May 2024.
(Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438063/all/repview. Accessed May 6, 2024.
(Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438063/all/repview
(Ultra‐)long‐acting Insulin Analogues Versus NPH Insulin (human Isophane Insulin) for Adults With Type 2 Diabetes Mellitus [Internet]. In: Cochrane Abstracts. [cited 2024 May 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438063/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - (Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
ID - 438063
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438063/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -